Needham analyst Ryan MacDonald has maintained a Buy rating on Hinge Health and raised the price target to $76 from the previous $63. The revised target reflects an increased valuation outlook for the company.

Analyst Rating and Price Target

The recommendation from Needham reinforces confidence in Hinge Health's market position. The adjustment in the price target suggests a potential upside based on the firm's analysis.

Hinge Health, Inc. (NYSE: HNGE) has expanded its HingeSelect platform to include orthopedic surgery, now delivering coordinated care across the entire musculoskeletal (MSK) journey. The clinical expansion integrates physical therapy, specialist evaluations, imaging, non-surgical procedures, prehabilitation, surgery, and post-operative recovery into a single solution. By managing the full spectrum of care, Hinge Health seeks to address the overuse of surgery, which accounts for about half of MSK costs, with research suggesting up to half of orthopedic surgeries may not be medically necessary.

The HingeSelect network connects members to high-quality surgeons and supports them from pre-operation through recovery. The platform leverages a provider footprint of over 4,100 locations to deliver appropriate care from the start, utilizing in-house orthopedic specialists and a flagship digital care product. Personalized peri-surgical physical therapy, delivered digitally and in-person, has been shown to reduce post-surgical complications by 21%.

Cost and Utilization Impact

The integrated model is designed to drive significant cost reductions and efficiency improvements within MSK care. Hinge Health reports that its network, including surgery, offers high-quality care at costs up to 30-50% below standard benchmarks. Additionally, the program has demonstrated a reduction in imaging and surgery utilization by over 60% when compared to commercial benchmarks.

Strategic Positioning

"We've spent 11 years building a digital MSK solution with demonstrated clinical outcomes and real-world results. Still, our clients often ask us ‘what if a member needs surgery?'" said Daniel Perez, Co-Founder and CEO of Hinge Health. "Today we have that answer. We now provide an end-to-end MSK solution that addresses the entire care journey, not just one part of it."

Katie Kirkland, Director of Benefits and Wellbeing at Southern Company, highlighted the operational benefits for employers. "Historically, an employer would address MSK costs by stringing together two to three solutions and hoping they worked together. Hinge Health has created one seamless solution."